Rise in pregnancies in sub-Saharan Africa linked to antiretroviral therapy

After beginning antiretroviral therapy, pregnancy rates in HIV-infected women increase, according to new research carried out in sub-Saharan Africa.

The research was carried out as part of a multi-country HIV treatment programme and has been published in PLoS medicine.

Landon Myer from the University of Cape Town in South Africa analysed data from the Mother-to-Child Transmission-Plus (MTCT-Plus) initiative.

The ways that antiretroviral therapy affected pregnancy rates in HIV-infected women were observed.

Over a period of four years, the researchers discovered that almost a third of the women that started the therapy became pregnant.

It was also revealed that the chance of becoming pregnant increased over time in women that had started to receive the therapy.

For women that were not receiving antiretroviral therapy, the pregnancy rates remained low.

Antiretroviral therapy reduces, but does not completely remove, the chances of a mother passing HIV on to her child.

A recent study published by PLoS One, found that a laboratory marker could effectively predict whether combination antiretroviral therapy will fail in HIV patients, the AIDS Beacon reported.

Posted by Alexandra GeorgeADNFCR-2094-ID-19608354-ADNFCR